VVT Med Signs Five-Year Exclusive Distribution Deal With Calment Medical in Poland

• VVT Med signed a five-year exclusive distribution agreement with Calment Medical for ScleroSafe in Poland, effective Oct. 15, 2026.
• Annual purchase targets total approximately CAD 1.4 million over the term; actual revenue depends on distributor performance.
• Calment Medical replaces the previous distributor, building on more than 1,000 ScleroSafe procedures performed in Poland.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VVT Med Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611040700CANADANWCANADAPR_C2311) on November 04, 2026, and is solely responsible for the information contained therein.